Helicobacter pylori eradication and metachronous gastric cancer

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 5, 2014, Pages 801-803

  Graham, David Y ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; MICRORNA; ANTIINFECTIVE AGENT; ANTIULCER AGENT;

ATROPHIC GASTRITIS; BACTERIAL CLEARANCE; BACTERIAL OVERGROWTH; CANCER IMMUNOTHERAPY; CANCER RISK; CANCER SURGERY; CELL TRANSDIFFERENTIATION; CHILDHOOD DISEASE; DNA METHYLATION; DOUBLE STRANDED DNA BREAK; DOWN REGULATION; EARLY CANCER; EDITORIAL; ENDOSCOPIC SURGERY; GENE EXPRESSION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; METACHRONOUS GASTRIC CANCER; NONHUMAN; POPULATION RISK; STOMACH CANCER; CARCINOMA; COMPLICATION; ENDOSCOPY; FEMALE; HELICOBACTER INFECTIONS; MALE; PROCEDURES; STOMACH NEOPLASMS;

ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CARCINOMA; ENDOSCOPY; FEMALE; HELICOBACTER INFECTIONS; HUMANS; MALE; STOMACH NEOPLASMS;

EID: 84899101804     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.10.029     Document Type: Editorial

References (17)

1. Choi J., Kim S.G., Yoon H., et al. Eradication of Helicobacter pylori after endoscopic resection of gastric tumors does not reduce incidence of metachronous gastric carcinoma. Clin Gastroenterol Hepatol 2014, 12:793-800.
2. Uemura N., Mukai T., Okamoto S., et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997, 6:639-642.
3. Fukase K., Kato M., Kikuchi S., et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008, 372:392-397.
4. Shiotani A., Cen P., Graham D.Y. Eradication of gastric cancer is now both possible and practical. Semin Cancer Biol 2013, 23:492-501.
5. Correa P., Cuello C., Gordillo G., et al. The gastric microenvironment in populations at high risk to stomach cancer. Natl Cancer Inst Monogr 1979, 53:167-170.
6. Graham D.Y., Asaka M. Eradication of gastric cancer and more efficient gastric cancer surveillance in Japan: two peas in a pod. JGastroenterol 2010, 45:1-8.
7. Correa P., Haenszel W., Cuello C., et al. Amodel for gastric cancer epidemiology. Lancet 1975, 2:58-60.
8. Rugge M., Fassan M., Pizzi M., et al. Letter: gastric cancer and pernicious anaemia-often Helicobacter pylori in disguise. Aliment Pharmacol Ther 2013, 37:764-765.
9. El-Zimaity H.M., Ota H., Graham D.Y., et al. Patterns of gastric atrophy in intestinal type gastric carcinoma. Cancer 2002, 94:1428-1436.
10. Schmidt P.H., Lee J.R., Joshi V., et al. Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma. Lab Invest 1999, 79:639-646.
11. Goldenring J.R., Nam K.T. Oxyntic atrophy, metaplasia, and gastric cancer. Prog Mol Biol Transl Sci 2010, 96:117-131.
12. Peng J., Wang Y. Epidemiology, pathology and clinical management of multiple gastric cancers: a mini-review. Surg Oncol 2010, 19:e110-e114.
13. Mantovani A., Cassatella M.A., Costantini C., et al. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 2011, 11:519-531.
14. Nishizawa T., Suzuki H. The role of microRNA in gastric malignancy. Int J Mol Sci 2013, 14:9487-9496.
15. Graham D.Y., Shiotani A., El-Zimaity H.M. Chromoendoscopy points the way to understanding recovery of gastric function after Helicobacter pylori eradication. Gastrointest Endosc 2006, 64:686-690.
16. Miyoshi E., Haruma K., Hiyama T., et al. Microsatellite instability is a genetic marker for the development of multiple gastric cancers. Int J Cancer 2001, 95:350-353.
17. Shiotani A., Murao T., Kimura Y., et al. Identification of serum miRNAs as novel non-invasive biomarkers for detection ofhigh risk for early gastric cancer. Br J Cancer 2013, 109:2323-2330.